What is Health Catalyst Inc?
provides data and analytics technology and services to healthcare organizations in the United States.
HCAT · Verdict
Moderate reward · high risk
HCAT's standout is valuation; balance sheet and profitability weigh on the picture.
Based on 88% data coverage
HCAT · Verdict
P/E 10.0× · PEG 0.14
Current ratio 1.43
-23% net margin · -31% ROE
Weak vs peers
-1% free-cash-flow margin
Rev +8.2% CAGR · earnings -23.2%
Model-based scoring. For information only — not financial advice.
provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments, Technology and Professional Services. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 126.61M.
The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are high — this profile reflects meaningful downside exposure.
For informational purposes only. Not financial advice.